Martin A Sticht1,2,3,4,5, David J Lau1,2,3,4, Catherine M Keenan1,5, Jean-Baptiste Cavin1,5, Maria Morena1,2,3,4, Venkata Kiran Vemuri6, Alexandros Makriyannis6, Benjamin F Cravatt7, Keith A Sharkey1,5, Matthew N Hill1,2,3,4. 1. Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. 2. Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, AB, Canada. 3. Dept. of Cell Biology and Anatomy, University of Calgary, Calgary, AB, Canada. 4. Dept. of Psychiatry, University of Calgary, Calgary, AB, Canada. 5. Dept. of Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada. 6. Center for Drug Discovery, Northeastern University, Boston, MA, USA. 7. The Skaggs Institute for Chemical Biology and Dept. of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, USA.
Abstract
BACKGROUND AND PURPOSE: Stress is known to reduce food intake. Many aspects of the stress response and feeding are regulated by the endocannabinoid system, but the roles of anandamide (AEA) and 2-arachidonoyl glycerol (2-AG) in stress-induced anorexia are unclear. EXPERIMENTAL APPROACH: Effects of acute restraint stress on endocannabinoids were investigated in male Sprague-Dawley rats. Systemic and central pharmacological inhibition of fatty acid amide hydrolase (FAAH) or monoacylglycerol lipase (MAGL) was used to assess the effects of elevated AEA and 2-AG on homeostatic feeding and on food consumption after stress. Animals were pretreated with the FAAH inhibitor, PF-04457845, or the MAGL inhibitor, MJN110, before 2 h acute restraint stress or 2 h homecage period without food. KEY RESULTS: Restraint stress decreased hypothalamic and circulating AEA, with no effect in the gastrointestinal tract, while 2-AG content in the jejunum (but not duodenum) was reduced. PF-04457845 (30 μg), given i.c.v., attenuated stress-induced anorexia via CB1 receptors, but reduced homeostatic feeding in unstressed animals through an unknown mechanism. On the other hand, systemic administration of MJN110 (10 mg·kg-1 ) reduced feeding, regardless of stress or feeding status and inhibited basal intestinal transit in unstressed rats. The ability of MAGL inhibition to reduce feeding in combination with stress was independent of CB1 receptor signalling in the gut as the peripherally restricted CB1 receptor antagonist, AM6545 did not block this effect. CONCLUSIONS AND IMPLICATIONS: Our data reveal diverse roles for 2-AG and AEA in homeostatic feeding and changes in energy intake following stress. LINKED ARTICLES: This article is part of a themed section on 8th European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc.
BACKGROUND AND PURPOSE: Stress is known to reduce food intake. Many aspects of the stress response and feeding are regulated by the endocannabinoid system, but the roles of anandamide (AEA) and 2-arachidonoyl glycerol (2-AG) in stress-induced anorexia are unclear. EXPERIMENTAL APPROACH: Effects of acute restraint stress on endocannabinoids were investigated in male Sprague-Dawley rats. Systemic and central pharmacological inhibition of fatty acid amide hydrolase (FAAH) or monoacylglycerol lipase (MAGL) was used to assess the effects of elevated AEA and 2-AG on homeostatic feeding and on food consumption after stress. Animals were pretreated with the FAAH inhibitor, PF-04457845, or the MAGL inhibitor, MJN110, before 2 h acute restraint stress or 2 h homecage period without food. KEY RESULTS: Restraint stress decreased hypothalamic and circulating AEA, with no effect in the gastrointestinal tract, while 2-AG content in the jejunum (but not duodenum) was reduced. PF-04457845 (30 μg), given i.c.v., attenuated stress-induced anorexia via CB1 receptors, but reduced homeostatic feeding in unstressed animals through an unknown mechanism. On the other hand, systemic administration of MJN110 (10 mg·kg-1 ) reduced feeding, regardless of stress or feeding status and inhibited basal intestinal transit in unstressed rats. The ability of MAGL inhibition to reduce feeding in combination with stress was independent of CB1 receptor signalling in the gut as the peripherally restricted CB1 receptor antagonist, AM6545 did not block this effect. CONCLUSIONS AND IMPLICATIONS: Our data reveal diverse roles for 2-AG and AEA in homeostatic feeding and changes in energy intake following stress. LINKED ARTICLES: This article is part of a themed section on 8th European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc.
Authors: Nathan K Evanson; Jeffrey G Tasker; Matthew N Hill; Cecilia J Hillard; James P Herman Journal: Endocrinology Date: 2010-08-11 Impact factor: 4.736
Authors: Matthew N Hill; Ryan J McLaughlin; Bin Pan; Megan L Fitzgerald; Christopher J Roberts; Tiffany T-Y Lee; Ilia N Karatsoreos; Ken Mackie; Victor Viau; Virginia M Pickel; Bruce S McEwen; Qing-song Liu; Boris B Gorzalka; Cecilia J Hillard Journal: J Neurosci Date: 2011-07-20 Impact factor: 6.167
Authors: Luis A Natividad; Matthew W Buczynski; Melissa A Herman; Dean Kirson; Christopher S Oleata; Cristina Irimia; Ilham Polis; Roberto Ciccocioppo; Marisa Roberto; Loren H Parsons Journal: Biol Psychiatry Date: 2017-01-13 Impact factor: 13.382
Authors: J Megan Gray; Christopher D Wilson; Tiffany T Y Lee; Quentin J Pittman; Jan M Deussing; Cecilia J Hillard; Bruce S McEwen; Jay Schulkin; Ilia N Karatsoreos; Sachin Patel; Matthew N Hill Journal: Psychoneuroendocrinology Date: 2016-01-11 Impact factor: 4.905
Authors: Stephen Ph Alexander; John A Cidlowski; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2017-12 Impact factor: 8.739
Authors: Martin A Sticht; David J Lau; Catherine M Keenan; Jean-Baptiste Cavin; Maria Morena; Venkata Kiran Vemuri; Alexandros Makriyannis; Benjamin F Cravatt; Keith A Sharkey; Matthew N Hill Journal: Br J Pharmacol Date: 2018-08-22 Impact factor: 8.739
Authors: Karen Jaqueline Paredes-Ruiz; Karla Chavira-Ramos; Mario Orozco-Morales; Cimen Karasu; Alexey A Tinkov; Michael Aschner; Abel Santamaría; Ana Laura Colín-González Journal: Neurotox Res Date: 2021-11-06 Impact factor: 3.911
Authors: Stuart M Brierley; Beverley Greenwood-Van Meerveld; Giovanni Sarnelli; Keith A Sharkey; Martin Storr; Jan Tack Journal: Nat Rev Gastroenterol Hepatol Date: 2022-09-27 Impact factor: 73.082
Authors: Malte Feja; Martin P K Leigh; Ajay N Baindur; Justin J McGraw; Ken T Wakabayashi; Benjamin F Cravatt; Caroline E Bass Journal: Neuropharmacology Date: 2019-10-17 Impact factor: 5.250
Authors: Haley A Vecchiarelli; Maria Morena; Catherine M Keenan; Vincent Chiang; Kaitlyn Tan; Min Qiao; Kira Leitl; Alessia Santori; Quentin J Pittman; Keith A Sharkey; Matthew N Hill Journal: Neuropsychopharmacology Date: 2021-01-15 Impact factor: 7.853
Authors: Maria Morena; Andrei S Nastase; Alessia Santori; Benjamin F Cravatt; Rebecca M Shansky; Matthew N Hill Journal: Br J Pharmacol Date: 2021-01-13 Impact factor: 9.473